Completed PHASE2 INTERVENTIONAL 2-arm NCT00027053

Trazodone for Sleep Disturbance in Early Alcohol Recovery (SIESTA)

Trazodone for Sleep Disturbance - Early Alcohol Recovery

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Updated 6 times since 2017 Last updated: May 11, 2010 Started: Jun 30, 2002 Primary completion: Jan 31, 2006 Completion: Jun 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00027053, this PHASE2 trial focuses on Alcoholism and remains completed. Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), it has been updated 6 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jun 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Rhode Island Hospital

Data source: Rhode Island Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Providence, United States